Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps

Nature Medicine

Volumn 21, Issue 4, 2015, Pages 407-413

  Guo, Tiannan ^a   Kouvonen, Petri ^a,b   Koh, Ching Chiek ^a,c   Gillet, Ludovic C ^a   Wolski, Witold E ^a,d   Röst, Hannes L ^a,e   Rosenberger, George ^a,e   Collins, Ben C ^a   Blum, Lorenz C ^a,d   Gillessen, Silke ^f   Joerger, Markus ^f   Jochum, Wolfram ^f   Aebersold, Ruedi ^a,e  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d SystemsXch   (Switzerland)

^e UNIVERSITY OF ZURICH   (Switzerland)

^f CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ION; PEPTIDE; PROTEOME;

BIOPSY; CHEMISTRY; HUMAN; KIDNEY; KIDNEY CARCINOMA; KIDNEY TUMOR; MASS SPECTROMETRY; METABOLISM; PRESSURE; PROCEDURES; PROTEOMICS; REPRODUCIBILITY;

BIOPSY; CARCINOMA, RENAL CELL; HUMANS; IONS; KIDNEY; KIDNEY NEOPLASMS; MASS SPECTROMETRY; PEPTIDES; PRESSURE; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS;

EID: 84939991970     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3807     Document Type: Article

References (39)

1. Liotta, L. & Petricoin, E. Molecular profiling of human cancer. Nat. Rev. Genet. 1, 48-56 (2000).
2. van 't Veer, L.J. et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536 (2002).
3. Sotiriou, C. & Pusztai, L. Gene-expression signatures in breast cancer. N. Engl. J. Med. 360, 790-800 (2009).
4. Barrett, T. et al. NCBI GEO: archive for high-throughput functional genomic data. Nucleic Acids Res. 37, D885-D890 (2009).
5. Forbes, S.A. et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res. 43, D805-D811 (2015).
6. Cancer Genome Atlas Research Network, Weinstein, J.N. et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet. 45, 1113-1120 (2013).
7. Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834-838 (2005).
8. Sreekumar, A. et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457, 910-914 (2009).
9. Kononen, J. et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4, 844-847 (1998).
10. Haab, B.B. Antibody arrays in cancer research. Mol. Cell Proteomics 4, 377-383 (2005).
11. Domon, B. & Aebersold, R. Options and considerations when selecting a quantitative proteomics strategy. Nat. Biotechnol. 28, 710-721 (2010).
12. Gillet, L.C. et al. Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol. Cell. Proteomics 11, O111.016717 (2012).
13. Liu, Y. et al. Quantitative measurements of N-linked glycoproteins in human plasma by SWATH-MS. Proteomics 13, 1247-1256 (2013).
14. Collins, B.C. et al. Quantifying protein interaction dynamics by SWATH mass spectrometry: application to the 14-3-3 system. Nat. Methods 10, 1246-1253 (2013).
15. Powell, B.S., Lazarev, A.V., Carlson, G., Ivanov, A.R. & Rozak, D.A. Pressure cycling technology in systems biology. Methods Mol. Biol. 881, 27-62 (2012).
16. López-Ferrer, D. et al. Application of pressurized solvents for ultrafast trypsin hydrolysis in proteomics: proteomics on the fly. J. Proteome Res. 7, 3276-3281 (2008).
17. Glatter, T. et al. Large-scale quantitative assessment of different in-solution protein digestion protocols reveals superior cleavage efficiency of tandem Lys-C/trypsin proteolysis over trypsin digestion. J. Proteome Res. 11, 5145-5156 (2012).
18. Röst, H. et al. OpenSWATH: Automated, targeted analysis of mass spectrometric data generated by data-independent acquisition. Nat. Biotechnol. 32, 219-223 (2014).
19. Rosenberger, G., Ludwig, C., Rost, H.L., Aebersold, R. & Malmstrom, L. aLFQ: an R-package for estimating absolute protein quantities from label-free LC-MS/MS proteomics data. Bioinformatics 30, 2511-2513 (2014).
20. Picotti, P., Bodenmiller, B., Mueller, L.N., Domon, B. & Aebersold, R. Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics. Cell 138, 795-806 (2009).
21. Algaba, F. et al. Current pathology keys of renal cell carcinoma. Eur. Urol. 60, 634-643 (2011).
22. Tan, P.H. et al. Renal tumors: diagnostic and prognostic biomarkers. Am. J. Surg. Pathol. 37, 1518-1531 (2013).
23. Kuster, B., Schirle, M., Mallick, P. & Aebersold, R. Scoring proteomes with proteotypic peptide probes. Nat. Rev. Mol. Cell Biol. 6, 577-583 (2005).
24. Beck, M. et al. The quantitative proteome of a human cell line. Mol. Syst. Biol. 7, 549 (2011).
25. Wi͆niewski, J.R. et al. Extensive quantitative remodeling of the proteome between normal colon tissue and adenocarcinoma. Mol. Syst. Biol. 8, 611 (2012).
26. Addona, T.A. et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat. Biotechnol. 27, 633-641 (2009).
27. 't Hoen, P.A. et al. Reproducibility of high-throughput mRNA and small RNA sequencing across laboratories. Nat. Biotechnol. 31, 1015-1022 (2013).
28. Sabidó, E. et al. Targeted proteomics reveals strain-specific changes in the mouse insulin and central metabolic pathways after a sustained high-fat diet. Mol. Syst. Biol. 16, 681 (2013).
29. Escher, C. et al. Using iRT, a normalized retention time for more targeted measurement of peptides. Proteomics 12, 1111-1121 (2012).
30. Leitner, A. et al. Expanding the chemical cross-linking toolbox by the use of multiple proteases and enrichment by size exclusion chromatography. Mol. Cell. Proteomics 11, M111.014126 (2012).
31. MacLean, B., Eng, J.K., Beavis, R.C. & McIntosh, M. General framework for developing and evaluating database scoring algorithms using the TANDEM search engine. Bioinformatics 22, 2830-2832 (2006).
32. Geer, L.Y. et al. Open mass spectrometry search algorithm. J. Proteome Res. 3, 958-964 (2004).
33. Deutsch, E.W. et al. A guided tour of the Trans-Proteomic Pipeline. Proteomics 10, 1150-1159 (2010).
34. Kunszt, P. et al. iPortal: the Swiss Grid Proteomics Portal: requirements and new features based on experience and usability considerations. Concurrency and Computation: Practice and Experience 27, 433-445 (2015).
35. Kessner, D., Chambers, M., Burke, R., Agus, D. & Mallick, P. ProteoWizard: open source software for rapid proteomics tools development. Bioinformatics 24, 2534-2536 (2008).
36. Sturm, M. et al. OpenMS: an open-source software framework for mass spectrometry. BMC Bioinformatics 9, 163 (2008).
37. Vizcaíno, J.A. et al. The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res. 41, D1063-D1069 (2013).
38. Huber, W., von Heydebreck, A., Sultmann, H., Poustka, A. & Vingron, M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18 (suppl. 1), S96-S104 (2002).
39. Bolstad, B.M., Irizarry, R.A., Astrand, M. & Speed, T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19, 185-193 (2003).